Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Park Medi World Q4 Results: Stock gives up initial spurt despite revenue growth, margin expansion
The group now consolidates 22 subsidiaries, spanning hospital brands including Aggarwal Hospital, Blue Heavens Healthcare, Park Medicity, Kailash Super-Speciality, and Umkal Healthcare, among others.
Stocks in news: Groww, Dr Reddy's, Waaree Energies, Lenskart, SBI
Markets experienced a sharp risk-off session on Monday, with indices declining amid broad selling. Investors are advised to avoid aggressive index bets and await clearer directional signals. Pharma and healthcare stocks remain preferred, while dips in energy and metal sectors offer accumulation opportunities.
Which sectors saw the biggest FII inflows and outflows in April?
Foreign investors remained net sellers of Indian equities in April, though the pace of outflows eased sharply from March. FIIs turned buyers in sectors such as power, capital goods and metals, while financial services, healthcare, oil & gas and automobiles continued to witness heavy selling pressure amid global uncertainty.
Samsung strengthens enterprise push with AI-powered Business Experience Studio in Gurugram
Samsung has launched a new Business Experience Studio in Gurugram. This center demonstrates AI-powered solutions for industries like retail, banking, and healthcare. The initiative supports India's digital transformation. Samsung aims to bring these intelligent, connected business environments to more cities. The studio also serves as a hub for creating customized solutions with partners.
Star Health to launch affordable health insurance plans targeting tier 2, 3 markets
As healthcare expenses soar, Star Health is bracing for premium increases in the next fiscal year. In a proactive move, the insurer is rolling out a series of affordable health insurance options tailored for smaller urban areas. These plans will incorporate a curated list of hospitals to not only streamline costs but also enhance accessibility for policyholders in these communities.
52 of 112 FY26 IPOs below issue price; analysts advise selective buying
Stocks such as Anlon Healthcare, Jaro Institute, VMS TMT, Shree Ram Twistex and Glottis are down in the range of 50 to 80 per cent, as per data shared by PRIME Database.
Carlyle buys RCM providers Knack & Equalize for $600 million
Carlyle Group is building a global healthcare revenue cycle management platform. The firm acquired majority stakes in US companies Knack and Equalize. These companies will merge to form a new entity. Carlyle plans to invest significantly and aims for a public listing this fiscal year. This move strengthens their presence in technology and tech-enabled services.
Carlyle buys majority stake in Knack, EqualizeRCM to build AI-led healthcare billing platform
The private equity firm is betting on consolidation in a fragmented US billing services market, with plans to scale via acquisitions and global delivery
Carlyle acquires Knack RCM and Equalize RCM to create an AI-native, global multi-specialty healthcare RCM platform
Global investment firm Carlyle has acquired a majority stake in US healthcare revenue cycle management providers Knack RCM and EqualizeRCM. This move aims to create a global, AI-native, multi-specialty RCM platform. The combined entity will leverage AI and global delivery to enhance operational scale and client outcomes, addressing critical financial risks for healthcare providers.
Buy, Sell Or Hold: Kalyan Jewellers, Bajaj Auto, Eternal, Siemens Energy And Max Healthcare — Ask Profit
Experts shared buy, sell and hold recommendations on NDTV Profit's 'Ask Profit' show.
India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI
India is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual property protection for pharmaceuticals. India maintains its intellectual property regime is compliant with international trade rules. This ongoing issue reflects long-standing differences between the two nations. India's stance aims to protect its generics industry and ensure access to affordable healthcare worldwide.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.